- The Modified Melphalan-Cladribine- Busulfan-Cyclophosphamide (MCBC) Conditioning Regimen Improved Relapse-Free Survival after Allo- HSCT in Refractory/Relapsed AMLZhang, Xiaoyu; Chen, Shulian; Zhai, Weihua; He, Yi; Feng, Sizhou; Han, Mingzhe; Niu, Ting; Xu, Yajing; Gao, Guangxun; Fan, Shengjin; Zhou, Zepin; Zhou, Fang; Xi, Rui; Liu, Li; Yang, Wei; Zhang, Xi; Liu, Qifa; Jiang, Erlie65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- Prediction Model for Early Recurrence after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with CMML: A Nationwide Representative Multicenter StudyZhou, Jianying; Wang, Song; Niu, Ting; Jiang, Ming; Wang, Shunqing; Wang, Wen; Zhang, Xi; Dong, Yujun; Wan, Dingming; Du, Xin; Wei, Xudong; Zhu, Han; Li, Yuhua; Bi, Kehong; Song, Xianmin; Chen, Yi; Liu, Li; Luo, Yi; Zhou, Yuhong; Li, Xin; Xu, Yajing; Zhang, Yicheng; Liu, Xiaoliang; Yi, Hai; Huang, Xiaobing; Zhu, Zunmin; Yang, Jianmin; Zhou, Fang; Zhang, Xiaohui65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- The Efficacy and Safety of Modified Melphalan and Busulfan-Based Conditioning Regimen for Allogeneic-HSCT in Refractory/Relapsed or Persistent MRD Positive AML PatientsChen, Shulian; Zhang, Xiaoyu; Zhai, Weihua; He, Yi; Feng, Sizhou; Han, Mingzhe; Niu, Ting; Xu, Yajing; Gao, Guangxun; Fan, Shengjin; Zhou, Zeping; Zhou, Fang; Rui, Xi; Liu, Li; Yang, Wei; Liu, Qifa; Zhang, Xi; Jiang, Erlie64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
会议论文
Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
10阅读
